Protect Customers From Risks Of Critical Disease, Manulife Indonesia And Bank Danamon Launch Main Protects Andalan Critical Prima

Photo: Doc. Danamon

JAKARTA - Manulife Indonesia and PT Bank Danamon Indonesia Tbk (Danamon) are now launching Main Critical Andalan Protection (PPKA), the latest insurance products through their bancassurance cooperation to provide financial protection for the Indonesian people as a result of the bancassurance partnership.

This traditional insurance product offers comprehensive protection against major critical diseases such as heart, stroke, cancer, and kidney failure with ease of underwriting process that facilitates customer experience. This product also provides calm of mind for Manulife customers with premium features to definitely return to a certain situation, helping customers prepare for future health challenges and financial impacts that often arise from these diseases.

PPKA provides protection against the four most common critical diseases in Indonesia, in accordance with data from the Ministry of Health, namely cancer, heart, stroke, and kidney failure. A simple underwriting process (Simplified Issue Offer) ensures that customers can quickly and easily access coverage for these high-risk diseases.

Customers will receive double protection in the form, coverage money and total refund of premiums that have been paid (under certain conditions) if diagnosed by one of the four diseases. Not limited by the above critical illness, this product provides additional protection benefits (safety-net), if customers are treated in the ICU for a minimum of 5 days or undergo an anganpollasti action.

"Manulife Indonesia and Bank Danamon are committed to listening to customer needs. The launch of Main Critical Protection Andalan (PPKA) offers comprehensive protection to help customers face serious health challenges and reduce financial pressure. In addition, celebrating our 40 years of presence in Indonesia, Manulife is always committed to continuing to assist customers with innovative and reliable solutions," said Novita Rumnanggun, Vice President Director & Deputy CEO of Manulife Indonesia. in his statement, Tuesday, March 11.

Danamon and its Main Company MUFG, members of the Company group and its strategic partners, including Manulife Indonesia, are committed to continuing to transform as a financial group to become trusted financial partners who always innovate and are customer-oriented.

"One form of our commitment as a financial group is to provide innovations that can help meet financial needs and provide financial solutions that suit customer needs. For this reason, together with Manulife Indonesia, we present PPKA insurance products that are trying to support and prepare customers' finances to deal with these four critical diseases, so that if this unwanted thing happens, customers can focus on the recovery process. With this PPKA insurance product, Danamon and Manulife Indonesia help provide protection for customers to ensure that customers do not face financial difficulties after being diagnosed with critical diseases," said Ivan Jaya, Consumer Funding & Wealth Business Head, PT Bank Danamon Indonesia Tbk.

Manulife Asia Care Survey 2024 noted that the most worrying diseases by the people of Indonesia are heart disease (40 percent), stroke (35 percent), cancer (22 percent) and kidney disease (17 percent). The cost of treating this disease has a major impact on family economic conditions.

According to BPJS data, the cost of treating catastrophic diseases including heart disease, cancer, stroke, kidney failure borne by BPJS Kesehatan in 2022 almost reached IDR 24.1 trillion, an increase of 34.3 percent compared to the previous year. Even though the cost of treatment is borne, patients are still facing economic burdens due to lifestyle changes after being diagnosed with critical illness.

Responding to this concern, PPKA offers a solution to protect customers' financial security and ensure they are ready to face unexpected costs such as patient accommodation costs and long-term maintenance costs caused by critical diseases that are often not small.

PPKA is a continuation of Manulife Indonesia's long-term partnership with Bank Danamon. The two companies are committed to continuing to innovate and provide comprehensive protection solutions to meet customers' financial protection needs and answer their health needs in the future.